Accuracy and performance of the WHO 2015 and WHO 2019 HIV testing strategies across epidemic settings
Jeffrey W. Eaton,Anita Sands,Magdalena Barr-DiChiara,Muhammad S Jamil,Rachel Baggaley,Beth A. Tippett Barr,Thokozani Kalua,Andreas Jahn,Mathieu Maheu-Giroux,Cheryl Johnson +9 more
Reads0
Chats0
TLDR
As positivity among persons testing for HIV reduces below 5% in nearly all settings, implementation of the WHO 2019 testing strategy will ensure that positive predictive value remains above the 99% target threshold, averting misdiagnoses and ART initiations among HIV unin infected people.Abstract:
Background WHO 2019 HIV testing guidelines recommended a standard HIV testing strategy consisting of three consecutively HIV-reactive test results on serology assays to diagnose HIV infection. National HIV programmes in high prevalence settings currently using the strategy consisting of only two consecutive HIV-reactive tests should consider when to implement the new guideline recommendations. Methods and Findings We implemented a probability model to simulate outcomes of WHO 2019 and the two strategies recommended by WHO 2015 guidelines on HIV testing services. Each assay in the strategy was assumed independently 99% sensitivity and 98% specificity, the minimal thresholds required for WHO prequalification. For each strategy and positivity ranging 20% to 0.2%, we calculated the number of false-negative, false-positive, and inconclusive results; positive and negative predictive value (PPV, NPV); number of each assay used, and testing programme costs. We found that the NPV was above 99.9% for all scenarios modelled. Under the WHO 2015 two-test strategy, the PPV was below the 99% target threshold when positivity fell below 5%. For the WHO 2019 strategy, the PPV was above 99% for all positivity levels. The number reported ‘inconclusive’ was higher under the WHO 2019 strategy. Implementing the WHO 2019 testing strategy in Malawi, would require around 89,000 A3 tests in 2021, compared to 175,000 A2 tests and over 4.5 million A1 tests per year. The incremental cost of the WHO 2019 strategy was less than 2% in 2021 and declined to 0.9% in 2025. Conclusions As positivity among persons testing for HIV reduces below 5% in nearly all settings, implementation of the WHO 2019 testing strategy will ensure that positive predictive value remains above the 99% target threshold, averting misdiagnoses and ART initiations among HIV uninfected people. The incremental cost of implementing the WHO 2019 HIV testing strategy compared to the two-test strategy is negligible because the third assay accounts for a small and diminishing share of total HIV tests.read more
Citations
More filters
Journal ArticleDOI
The evolving HIV epidemic and its impact on the HIV testing algorithm: Is it time to change the HIV testing algorithm in South Africa?
TL;DR: In this paper, the authors provide an overview of the current state of the HIV epidemic and its impact on HIV testing, further they highlight areas of concern in changing from a 2-step to a 3-step test algorithm in the context of South Africa's HIV epidemic.
References
More filters
Journal ArticleDOI
Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data.
Katia Giguère,Jeffrey W. Eaton,Kimberly Marsh,Leigh F. Johnson,Cheryl Johnson,Eboi Ehui,Andreas Jahn,Ian Wanyeki,Francisco Mbofana,Fidèle Bakiono,Mary Mahy,Mathieu Maheu-Giroux +11 more
TL;DR: In this paper, the authors used data from 183 population-based surveys (including more than 2·7 million participants) and national HIV testing programme reports (315 country-years) from 40 countries in sub-Saharan Africa as inputs into a mathematical model to examine trends in knowledge of status among people living with HIV, median time from HIV infection to diagnosis, HIV testing positivity, and proportion of new diagnoses among all positive tests, adjusting for retesting.
Journal ArticleDOI
Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels.
John Stover,Robert Glaubius,Lynne M. Mofenson,Caitlin M Dugdale,Mary-Ann Davies,Gabriela Patten,Constantin T. Yiannoutsos +6 more
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to foreign substance abuse.
Journal ArticleDOI
When good news is bad news: psychological impact of false positive diagnosis of HIV
TL;DR: A series of four case who developed psychological difficulties and psychiatric morbidities after being informed they had been misdiagnosed with HIV-positive status highlights the implications a false diagnosis HIVpositive status can have, even when the diagnosis is rectified.
Journal ArticleDOI
The Estimation and Projection Package Age-Sex Model and the r-hybrid model: New tools for estimating HIV incidence trends in sub-Saharan Africa
Jeffrey W. Eaton,Tim Brown,Robert Puckett,Robert Glaubius,Kennedy K Mutai,Le Bao,Joshua A. Salomon,John Stover,Mary Mahy,Timothy B. Hallett +9 more
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to foreign substance abuse.
Journal ArticleDOI
A public health approach to addressing and preventing misdiagnosis in the scale-up of HIV rapid testing programmes.
TL;DR: The aim of this work is to provide a systematic review and meta-analysis of the determinants of infectious disease-related coronavirus death in Europe over a 25-year period and suggest a single cause of death, namely infection-related death, which is currently unknown.